Mercer Global Advisors Inc. ADV Acquires 2,622 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mercer Global Advisors Inc. ADV lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) by 36.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,737 shares of the exchange traded fund’s stock after acquiring an additional 2,622 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in SPDR S&P Biotech ETF were worth $808,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XBI. Alaska Permanent Fund Corp bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $151,331,000. Jane Street Group LLC lifted its holdings in SPDR S&P Biotech ETF by 111.4% during the 2nd quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock valued at $12,829,000 after purchasing an additional 1,682,382 shares during the last quarter. Two Sigma Advisers LP bought a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $105,480,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $91,300,000. Finally, Brown Advisory Inc. lifted its holdings in SPDR S&P Biotech ETF by 1,107.6% during the 3rd quarter. Brown Advisory Inc. now owns 970,255 shares of the exchange traded fund’s stock valued at $76,960,000 after purchasing an additional 889,912 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.8 %

Shares of XBI stock opened at $85.37 on Friday. SPDR S&P Biotech ETF has a 12-month low of $62.13 and a 12-month high of $95.18. The company has a market capitalization of $6.90 billion, a P/E ratio of 11.47 and a beta of 0.97. The firm has a 50-day moving average price of $79.78 and a 200 day moving average price of $82.16.

About SPDR S&P Biotech ETF

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.